首页|钙蛋白颗粒与慢性肾脏病G3~5D期患者冠状动脉钙化的相关性研究

钙蛋白颗粒与慢性肾脏病G3~5D期患者冠状动脉钙化的相关性研究

The correlation between calciprotein particles and coronary calcification in patients with chronic kid-ney disease at G3~5D stage

扫码查看
目的 分析钙蛋白颗粒(calciprotein particles,CPPs)与慢性肾脏病(chronic kidney disease,CKD)G3~5D期冠状动脉钙化的相关性,探讨CPPs分别对于血液透析(hemodialysis,HD)和非HD患者冠状动脉钙化的预测价值以及影响因素.方法 本研究采用单中心、横断面调查方法纳入CKDG3~5D患者75例,根据CKD分期分层、冠状动脉钙化积分(coronary artery calcification score,CACS)分组,将患者分为钙化组和无钙化组,比较CKD各期2组间CPPs的差异.应用二元Logistics回归分析CKD G3~5期(非透析)冠状动脉钙化的危险/保护因子.Kruskal-Wallis检验和Pearson卡方检验评估CPPs与HD冠状动脉钙化严重程度的关系.应用单因素线性回归分析CKD G3~5D期冠状动脉钙化人群CPPs的影响因素.结果 二元Logistics回归分析结果显示CPPs(每SD增加)是CKD G3~5期(非透析)冠状动脉钙化的独立保护因素,CPPs浓度每增加1个SD(10.20)与冠状动脉钙化风险降低73.4%相关(OR=0.266,95%CI:0.077~0.916,P=0.036).Kruskal-Wallis检验结果显示CPPs随着冠状动脉钙化严重程度升高(H=6.557,P=0.037),同时CACS水平随着CPPs增多而升高(H=7.440,P=0.024).Pearson卡方检验结果显示相比于低水平CPPs组,中、高水平CPPs组高度冠状动脉钙化的HD人群(CACS>100)占比更大,3组之间不同钙化严重程度的人群比例差异具有统计学意义(x2=9.800,P=0.044).单因素线性回归分析结果显示在CKD G3~5D期冠状动脉钙化患者中,CPPs与eGFR-EPI呈负相关(β=-0.424,P=0.004),与血肌酐(β=0.453,P<0.001)、血钙(β=0.328,P=0.014)呈正相关.结论 CPPs是CKD G3~5期(非透析)患者冠状动脉钙化的保护因子,与之相反,对于HD患者,CPPs越高提示冠状动脉钙化严重程度越高.eGFR-EPI、血肌酐、血钙可能是是CKD G3~5D期冠状动脉钙化患者CPPs变化的影响因素.
Objectives To analyze the correlation between calciprotein particles(CPPs)and coronary calcification in chronic kidney disease(CKD)G3~5D patients,and to discuss the predictive value and influ-encing factors of CPPs for coronary calcification in both hemodialysis(HD)and non-HD patients.Method This single-centered and cross-sectional survey study enrolled 75 CKD G3~5D patients.Based on CKD stage and coronary artery calcification score(CACS),the patients were divided into calcification group and non-calcification group to compare the differences of CPPs at different CKD stages between the two groups.The risk and protective factors for calcification in CKD G3~5(non-dialysis)patients were assessed using bi-variate logistic regression.The correlation between CPPs and degrees of coronary calcification in HD patients was evaluated using Kruskal-Wallis test and Pearson chi square test.The influencing factors for CPPs in CKD G3~5D patients with calcification were investigated using univariate linear regression.Result For CKD G3~5(non-dialysis)patients,bivariate logistic regression showed that CPPs(increased per SD)were the in-dependent protective factors for coronary calcification;an increase of one SD(10.20)of CPPs was associated with a 73.4%reduction in coronary calcification risk(OR:0.266,95%CI:0.077~0.916,P=0.036).Kruskal-Wallis test showed that CPPs increased with the increase of CACS(H=6.557,P=0.037),and CACS increased with the increase of CPPs(H=7.440,P=0.024).Pearson chi square test demonstrated that the proportion of HD patients with CACS>100 was more in the middle and high CPPs groups than that in the low CPPs group,and the ratios of calcification degrees were statistically different among the 3 CPPs groups(x2=9.800,P=0.044).Univariate linear regression showed a negative correlation between CPPs and eGFR-EPI(β=-0.424,P=0.004)and positive correlations between CPPs and serum levels of Scr(β=0.453,P<0.001)and calcium(β=0.328,P=0.014)in CKD G3~5D patients with coronary calcification.Conclusion In CKD G3~5(non-dialysis)patients,CPPs are the protective factors for coronary calcification.In contrast in HD patients,higher CPPs implies severer coronary calcification.Serum levels of eGFR-EPI,Scr and calcium are the potential fac-tors for CPPs changes in CKD G3~5D patients with coronary calcification.

Calciprotein particlesChronic kidney diseaseCoronary calcification

陈雨柔、王书婷、廖晟淳、叶朝阳

展开 >

201203 上海,上海中医药大学附属曙光医院肾病科

上海中医药大学中医肾病研究所

肝肾疾病病证教育部重点实验室(上海中医药大学)

上海市中医临床重点实验室

展开 >

钙蛋白颗粒 慢性肾脏病 冠状动脉钙化

国家自然科学基金面上项目华东片区及市级中医专科专病联盟建设项目上海市卫生健康委科研项目

82174289ZY2021-2023-03022014Y0382

2024

中国血液净化
中国医院协会

中国血液净化

CSTPCD
影响因子:1.54
ISSN:1671-4091
年,卷(期):2024.23(1)
  • 21